Walter Lloyd Sanders

CIK 1349943 · President Myriad Oncology · last filed 2018-10-02

Walter Lloyd Sanders is a President Myriad Oncology who has filed 7 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider disposed of $57.9K of MYGN on Oct 2, 2018. Current disclosed insider exposure totals $168.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$168.8K

Companies

2

Total Filings

7

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
MYGN	President Myriad Oncology	36,824	$4.33	$159.4K	$0	3	2018-10-02
GNTA	Senior VP & COO	5,000	$1.87	$9.3K	$0	2	2008-04-15

Recent Filings

7 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2018-10-02	MYGN	Disp (D)	−1,258	-$57.9K	EDGAR
2018-09-26	MYGN	Disp (D)	−1,664	-$77.6K	EDGAR
2018-09-18	MYGN	Disp (D)	−844	-$39.1K	EDGAR
2009-11-25	—	Sell (S)	−367,704	-$58.4K
2009-09-11	—	Mixed	+4,412,446	$0
2008-04-15	GNTA	Mixed	−104	$0	EDGAR
2007-01-17	GNTA	Grant (A)	—	$0	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.